Results 161 to 170 of about 64,952 (240)

Projected Reduction of Diabetes- and Obesity-Related Complication Risks Following the 12-Week Weight-Loss Phase of the RESET Study. [PDF]

J Health Econ Outcomes Res
Schwander B, Kerr KW, Rueda R, Camprubi-Robles M, Northway N, Lumsden C, Taylor L, Sulo S.   +7 more
europepmc   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, Sinan Yasaroglu, Tobias Moser, Andrea Harrer, Kitty Kratzer, Wolfgang Hitzl, Christiane Gradl, Martin Schmidauer, Patrick Roth, Harald Hegen, Peter Wipfler   +12 more
wiley   +1 more source

Effectiveness of Online Training on Cardiopulmonary Resuscitation and Automated External Defibrillator Use in Simulations With Rural Populations: Quasi-Experimental Community Intervention Study. [PDF]

JMIR Public Health Surveill
Taverna-Llauradó E, Martinez-Torres S, Roca-Biosca A, Pallejà-Millán M, Martín-Luján F, Rey-Reñones C.   +5 more
europepmc   +1 more source

Progressive Parkinsonism in PPP2R5D‐Related Neurodevelopmental Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT PPP2R5D‐related neurodevelopmental disorder (Houge–Janssens syndrome type 1) is a rare autosomal dominant condition characterized by macrocephaly, intellectual disability, and epilepsy. Progressive parkinsonism is an emerging adult phenotype that neurologists should be aware of since timely genetic diagnosis opens the door to disease‐modifying
Katerina Bernardi, Enrique Gonzalez Saez‐Diez, Joshua Rong, Beril Ay, Shabbir Merchant, Kathryn Yang, Darius Ebrahimi‐Fakhari   +6 more
wiley   +1 more source

Effectiveness of a Plan-Do-Study-Act cycle-based quality control circle in enhancing the research capacity of operating room nurses a pre-post intervention study. [PDF]

BMC Nurs
Yu X, Wang X, Yang Y, Hou W, Wang Z.
europepmc   +1 more source

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay, Merve Alaylioglu, Erdi Sahin, Sanem Sultan Yoruk Oner, Gulce Iskan, Gulce Cosku Yilmaz Cakan, Gozde Kizilates‐Evin, Emre Hari, Elif Kurt, Erdinc Dursun, Basar Bilgic, Hasmet Hanagasi, Hakan Gurvit, Tamer Demiralp, Duygu Gezen‐Ak, Bedia Samanci   +15 more
wiley   +1 more source

Innovation and progress towards TB elimination in New South Wales, Australia. [PDF]

IJTLD Open
Donnan EJ, Pett J, Furlong C, Ulbricht E, Massey PD, Sintchenko V, Marais BJ.   +6 more
europepmc   +1 more source

Exploring fidelity and its influence on effectiveness in an audit and feedback strategy implemented in a low-resource setting: an application of regression modeling. [PDF]

Implement Sci Commun
Dinis A, Fernandes Q, Augusto O, Weiner BJ, Gimbel S, Birru E, Uetela D, John-Stewart G, Gloyd S, Ramiro I, Sherr K.   +10 more
europepmc   +1 more source

Long-term Air Pollution and Overall and Regional Body Composition in Older Adults With Overweight or Obesity and Metabolic Syndrome. [PDF]

Diabetes Care
Curto A, Konieczna J, Colom A, Abete I, de Hoogh K, Hoek G, Salas-Salvadó J, Martín-Sánchez JV, Estruch R, Vidal J, Toledo E, García-Gavilán JF, de Paz JA, Casas R, Goñi-Ruiz N, Vázquez-Lorente H, Fitó M, Martínez JA, Romaguera D.   +18 more
europepmc   +1 more source